It can be said that prolonged, unopposed BCR-ABL1 activity enhances PRC2 activity in CP-CML, which leads to the methylation of PRC2-bound genes [55]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.